Podas Tablet 10/100 mg
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Sungwon Adcock Pharmaceutical Co., Ltd.
MFDS item code 202300187 · Approved 2023.01.10
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to help control blood sugar levels in patients with type 2 diabetes using both sitagliptin and dapagliflozin. It assists in effectively managing blood sugar levels when administered alongside dietary control and exercise therapy. This improves the efficiency of diabetes treatment.
One tablet of this medicine may be administered once daily, with or without food, to patients receiving sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole. - No dose adjustment is necessary if the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher. - Do not administer this medicine if the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73 m2. No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.
This medication contains sitagliptin and dapagliflozin, which are used for the treatment of diabetes. First, the sitagliptin component may cause rare but serious allergic reactions, so if symptoms such as rash or difficulty breathing occur, discontinue use immediately and consult a physician. Additionally, there is a risk of acute pancreatitis, an inflammation of the pancreas, so if symptoms like abdominal pain, nausea, or vomiting occur, inform healthcare personnel immediately. This medication is not for patients with type 1 diabetes, diabetic ketoacidosis, or those undergoing dialysis. Second, the dapagliflozin component may reduce body fluid volume, leading to decreased blood pressure or impaired kidney function; thus, patients with poor kidney function, elderly patients, or those taking diuretics should consult a physician before use. If symptoms of fluid volume decrease (dizziness, dehydration, etc.) appear, they should be reported immediately, and temporary discontinuation of use may be necessary. Furthermore, dapagliflozin may increase the risk of genital and urinary tract infections, so appropriate treatment is required if infection symptoms occur. Serious conditions such as diabetic ketoacidosis may arise, so watch for symptoms such as loss of appetite, abdominal pain, or difficulty breathing, and ketone levels should be checked regardless of blood sugar levels. Use of this medication is not recommended during pregnancy or breastfeeding, so consultation with a physician is essential. Finally, this medication, when used with insulin or sulfonylureas, may increase the risk of hypoglycemia; therefore, careful blood sugar control is necessary and dose adjustments may be needed if required. If any abnormal symptoms occur while taking this medication, please consult with medical personnel immediately.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a sealed container. It is best to keep the storage temperature between 1 and 30 degrees Celsius at room temperature. This helps maintain the efficacy of the medication and ensures safe usage.
Beige oval film-coated tablets
30 tablets/PTP [(10 tablets/PTP X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Sungwon Adcock Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.